Login
Super Investors Empery Asset Management, LP
EA

Empery Asset Management, LP

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$96.5M
Positions
34
Quarter ended
September 30, 2026
Filed
November 16, 2026

Reported portfolio value by quarter (8 quarters reported)

$113M $16.8M
Q4 21 Q2 22 Q4 25 Q2 26 Q3 26

$47.9M in Q4 2021 → $96.5M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
X4 Pharmaceuticals Inc 29.2% Added 40% 9,725,509 $28.2M
Empery Digital Inc 15.1% Added 65% 4,830,345 $14.5M
Moderna Inc Put 14.6% New 73,300 $14.1M
Outlook Therapeutics Inc 12.6% New 21,247,856 $12.2M
Nervgen Pharma Corp 6.5% Trimmed 17% 3,308,973 $6.32M
Zone Frontier Inc 2.7% New 20,000,000 $2.6M
PO Pyxis Oncology Inc 2.4% New 1,000,000 $2.33M
Cellectar Biosciences Inc 1.8% Added 404% 955,118 $1.76M
Amylyx Pharmaceuticals Inc 1.8% New 60,000 $1.75M
DI Dyadic Intl Inc Del 1.5% New 3,346,275 $1.49M
Tenaya Therapeutics Inc 1.3% Trimmed 45% 2,128,726 $1.28M
Greenland Energy Co 1.2% Unchanged 1,000,000 $1.17M
Femasys Inc 1.0% New 468,750 $1.01M
Cyngn Inc 1.0% Added 41% 1,310,422 $983K
CT Celldex Therapeutics Inc New Call 1.0% New 30,000 $972K
Quoin Pharmaceuticals Ltd 1.0% New 204,910 $934K
Clene Inc 0.9% Trimmed 76% 221,660 $904K
Ur-energy Inc 0.7% Unchanged 620,136 $670K
Precision Biosciences Inc 0.7% Trimmed 87% 102,292 $640K
Lantern Pharma Inc 0.6% Trimmed 36% 543,337 $549K
Satellos Bioscience Inc 0.5% Trimmed 46% 58,000 $493K
OA One And One Green Technologi 0.5% Trimmed 59% 311,976 $443K
Jaguar Uranium Corp 0.4% Trimmed 29% 345,580 $373K
Briacell Therapeutics Corp 0.4% Unchanged 300,000 $348K
Gossamer Bio Inc 0.3% New 24,954 $296K
Duke Robotics Corp 0.1% Unchanged 35,000 $52.2K
RT Renatus Tactical Acquis 0.0% Unchanged 50,000 $27K
Maris Tech Ltd 0.0% Unchanged 297,600 $20.9K
Spectral Ai Inc 0.0% Unchanged 33,336 $15.7K
Bnb Standard Corp 0.0% Unchanged 500,000 $10.8K
Nexera Technologies Ltd 0.0% Unchanged 360,577 $5.34K
Neurosense Therapeutics Ltd 0.0% Trimmed 4.9% 95,499 $4.3K
Fgi Industries Ltd 0.0% Unchanged 83,928 $4K
Nexgel Inc 0.0% Unchanged 90,000 $1.1K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 7 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 16, 2026

Company Action Shares changed Value of change % of portfolio
Moderna Inc New +73,300 +$14.1M 14.6%
Outlook Therapeutics Inc New +21,247,856 +$12.2M 12.6%
X4 Pharmaceuticals Inc Added +2,794,918 +$8.11M 29.2%
Empery Digital Inc Added +1,900,000 +$5.72M 15.1%
Annovis Bio Inc Exited −2,401,476 −$4.47M —
Precision Biosciences Inc Trimmed −673,801 −$4.22M 0.7%
AE Amc Entmt Hldgs Inc Exited −1,714,043 −$3.26M —
Clene Inc Trimmed −694,872 −$2.84M 0.9%
Zone Frontier Inc New +20,000,000 +$2.6M 2.7%
PO Pyxis Oncology Inc New +1,000,000 +$2.33M 2.4%

Showing the 10 largest of 31 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 11, 2026

Company Action Shares changed Value of change % of portfolio
X4 Pharmaceuticals Inc Trimmed −2,013,527 −$9.4M 37.4%
Precision Biosciences Inc Trimmed −1,192,786 −$9.38M 7.1%
Nervgen Pharma Corp New +4,000,000 +$8.24M 9.5%
Clene Inc New +916,532 +$5.64M 6.5%
Annovis Bio Inc New +2,401,476 +$4.47M 5.2%
IP Imperial Pete Inc Exited −877,645 −$3.76M —
Lantern Pharma Inc New +842,669 +$3.51M 4.1%
AE Amc Entmt Hldgs Inc New +1,714,043 +$3.26M 3.8%
US U S Energy Corp Del Exited −1,917,844 −$1.7M —
Scynexis Inc Exited −1,847,826 −$1.69M —

Showing the 10 largest of 31 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 08, 2026

Company Action Shares changed Value of change % of portfolio
Immuneering Corp Exited −2,674,950 −$17.6M —
IP Imperial Pete Inc Trimmed −2,305,306 −$9.87M 4.5%
Aduro Clean Technologies Inc Exited −571,046 −$5.92M —
VH Venu Hldg Corp New +1,007,729 +$3.34M 4.0%
Eos Energy Enterprises Inc Exited −249,726 −$2.86M —
Critical Metals Corp Trimmed −359,421 −$2.85M 1.3%
Surrozen Inc Exited −103,974 −$2.35M —
US U S Energy Corp Del New +1,917,844 +$1.7M 2.0%
Scynexis Inc New +1,847,826 +$1.69M 2.0%
Cyngn Inc New +957,784 +$1.59M 1.9%

Showing the 10 largest of 32 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 11, 2026

Company Action Shares changed Value of change % of portfolio
X4 Pharmaceuticals Inc New +8,951,105 +$35.8M 31.6%
Immuneering Corp New +2,674,950 +$17.6M 15.5%
Empery Digital Inc New +2,930,345 +$13.4M 11.8%
IP Imperial Pete Inc New +3,182,951 +$11.5M 10.2%
Precision Biosciences Inc New +2,194,635 +$9.13M 8.1%
Aduro Clean Technologies Inc New +571,046 +$5.92M 5.2%
Tenaya Therapeutics Inc New +5,414,101 +$3.85M 3.4%
Critical Metals Corp New +491,460 +$3.41M 3.0%
Eos Energy Enterprises Inc New +249,726 +$2.86M 2.5%
Surrozen Inc New +103,974 +$2.35M 2.1%

Showing the 10 largest of 107 changes.

Q3 2022

quarter ended September 30, 2022 · filed November 14, 2022

Company Action Shares changed Value of change % of portfolio
Meta Materials Inc Exited −4,370,568 −$4.5M —
Unity Biotechnology Inc New +4,411,645 +$1.74M 10.4%
SL Sellas Life Sciences Group I Trimmed −619,518 −$1.25M 3.7%
GT Greenwave Technology Solutio New +618,844 +$1.07M 6.4%
Sobr Safe Inc New +248,430 +$666K 4.0%
Mind Medicine Mindmed Inc New +187,500 +$656K 3.9%
Applied Therapeutics Inc Exited −675,000 −$640K —
Medicenna Therapeutics Corp New +589,316 +$489K 2.9%
A Athenex Inc New +1,452,103 +$391K 2.3%
Benitec Biopharma Inc New +796,837 +$296K 1.8%

Showing the 10 largest of 32 changes.

Q2 2022

quarter ended June 30, 2022 · filed August 12, 2022

Company Action Shares changed Value of change % of portfolio
Meta Materials Inc New +4,370,568 +$4.5M 24.4%
SL Sellas Life Sciences Group I New +927,984 +$2.07M 11.2%
89bio Inc New +400,000 +$1.29M 7.0%
Brc Inc Exited −269,212 −$1.2M —
Sunshine Biopharma Inc Exited −450,450 −$1.1M —
VC The Valens Company Inc Exited −400,000 −$688K —
NI Nisun Intl Ent Dvpmt Gp Co L Exited −672,556 −$658K —
Applied Therapeutics Inc New +675,000 +$640K 3.5%
The Oncology Institute Inc Exited −70,733 −$504K —
Calithera Biosciences Inc Exited −775,925 −$313K —

Showing the 10 largest of 37 changes.

Q1 2022

quarter ended March 31, 2022 · filed May 16, 2022

Company Action Shares changed Value of change % of portfolio
Ispecimen Inc Exited −466,333 −$3.64M —
Opy Acquisition Corp I Exited −300,000 −$2.96M —
Ampio Pharmaceuticals Inc Exited −4,262,409 −$2.43M —
MR Mount Rainier Acquisition Corp Exited −200,000 −$2.03M —
CA Cactus Acquisition Cop I Ltd Exited −200,000 −$2.02M —
Regulus Therapeutics Inc Exited −5,074,251 −$1.6M —
Alset Ehome International Inc Exited −2,594,480 −$1.45M —
TB Tc Biopharm Holdings PLC New +2,823,528 +$1.38M 6.5%
Stran & Company Inc Exited −201,208 −$1.22M —
Brc Inc New +269,212 +$1.2M 5.7%

Showing the 10 largest of 76 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support